Market Overview

UPDATE: J.P. Morgan Raises PT on Health Care REIT on Updated Model

Share:
Related HCN
5 NYSE Financial Stocks With The Highest EPS Growth Forecast For Next 5 Years
REITs Rejoice On Fed Remarks: Were These Top Gainers Driven By News?
The 3 Paradoxes Of Income Investing (Seeking Alpha)

In a report published Friday, J.P. Morgan reiterated its Neutral rating on Health Care REIT (NYSE: HCN), and slightly raised its price target from $63.00 to $64.00.

J.P. Morgan noted, “We are updating our model post 4Q earnings. As a result, we are lowering our 2013 FFO estimate by $0.09, to $3.78. In addition, we are lowering our 2014 FFO estimate by $0.10, to $4.00. Finally, we are increasing our 2013 YE price target by $1 to $64/share as a result of a slight increase in our payout ratio assumption.”

Health Care REIT closed on Thursday at $65.16.

Latest Ratings for HCN

DateFirmActionFromTo
Mar 2015CitigroupMaintainsNeutral
Feb 2015Deutsche BankMaintainsHold
Feb 2015Morgan StanleyUpgradesEqual-weightOverweight

View More Analyst Ratings for HCN
View the Latest Analyst Ratings

Posted-In: J.P. MorganAnalyst Color Price Target Analyst Ratings

 

Related Articles (HCN)

Around the Web, We're Loving...